Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-10-6
pubmed:abstractText
Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disease (PTLD) is a serious complication after allogeneic stem cell transplantation (SCT). The likelihood of PTLD is increased in the presence of specific risk factors. Monitoring of EBV DNA load and early administration of rituximab in patients with high EBV loads is recommended for high-risk patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1399-3062
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
393-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19497070-Adolescent, pubmed-meshheading:19497070-Adult, pubmed-meshheading:19497070-Aged, pubmed-meshheading:19497070-Antibodies, Monoclonal, pubmed-meshheading:19497070-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:19497070-Child, pubmed-meshheading:19497070-Child, Preschool, pubmed-meshheading:19497070-DNA, Viral, pubmed-meshheading:19497070-Epstein-Barr Virus Infections, pubmed-meshheading:19497070-Female, pubmed-meshheading:19497070-Herpesvirus 4, Human, pubmed-meshheading:19497070-Humans, pubmed-meshheading:19497070-Immunologic Factors, pubmed-meshheading:19497070-Infant, pubmed-meshheading:19497070-Lymphoproliferative Disorders, pubmed-meshheading:19497070-Male, pubmed-meshheading:19497070-Middle Aged, pubmed-meshheading:19497070-Polymerase Chain Reaction, pubmed-meshheading:19497070-Risk Factors, pubmed-meshheading:19497070-Stem Cell Transplantation, pubmed-meshheading:19497070-Viral Load, pubmed-meshheading:19497070-Young Adult
pubmed:year
2009
pubmed:articleTitle
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
pubmed:affiliation
Department of Medicine, Huddinge, Division of Haematology, Karolinska Institutet, Stockholm, Sweden. hamdy.omar@ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't